Jinhe Biotech: Net profit for the first half of 2025 increased by 51.52% year-on-year.

Golden Hebio announces that in the first half of 2025, the operating income was RMB 1.39 billion, a year-on-year increase of 30.45%. Net profit was RMB 138 million, a year-on-year increase of 51.52%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to increase capital reserves.